Intercure Ltd. - ordinary shares (NQ:INCR)

5.030 UNCHANGED

Delayed Quote Updated: 3:14 PM EDT, Oct 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intercure Ltd. - ordinary shares

< Previous 1 2 3 4 Next >

InterCure Enters Premium US Cannabis Market With ISHI Deal ↗

September 19, 2025

InterCure Ltd. (NASDAQ: INCR) acquires Botanico Ltd., known as ISHI, to strengthen its global cannabis portfolio.

Via Benzinga

Topics Cannabis

InterCure To Buy ISHI In All-Stock Transaction – Find Out More ↗

September 19, 2025

Via Stocktwits

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company ↗

September 14, 2024

InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A.

Via Benzinga

Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany ↗

August 30, 2024

Via Benzinga

Topics Cannabis

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

August 28, 2024

From InterCure

Via Business Wire

5 Value Stocks In The Healthcare Sector ↗

May 08, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

April 17, 2023

Via Benzinga

European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon ↗

July 18, 2024

Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling...

Via Benzinga

Topics Cannabis

Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ ↗

May 24, 2024

The potential rescheduling of cannabis in the U.S.

Via Benzinga

Topics Cannabis

InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference

May 22, 2024

From InterCure Ltd.

Via Business Wire

InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion ↗

May 02, 2024

"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges.

Via Benzinga

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

May 01, 2024

From InterCure Ltd.

Via Business Wire

This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict ↗

April 01, 2024

Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany.

Via Benzinga

Topics Cannabis

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

April 01, 2024

From InterCure Ltd.

Via Business Wire

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

March 22, 2024

From InterCure Ltd.

Via Business Wire

Canndoc Reports Record Revenue Amid Cannabis Market Turmoil ↗

September 01, 2023

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023,

Via Benzinga

Topics Cannabis

Cannabis Stock Movers For August 18, 2023 ↗

August 18, 2023

Via Benzinga

Topics Cannabis

Cannabis Stock Gainers And Losers From August 24, 2023 ↗

August 24, 2023

Via Benzinga

Topics Cannabis

Stocks That Hit 52-Week Lows On Wednesday ↗

July 05, 2023

Wednesday's session saw 43 companies set new 52-week lows.

Via Benzinga

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 ↗

August 21, 2023

Via Benzinga

Topics Cannabis

Medical Cannabis Company Better Is Suing InterCure For $35M ↗

June 15, 2023

Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure (NASDAQ: INCR) for $35 million.

Via Benzinga

InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details ↗

May 16, 2023

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million)...

Via Benzinga

Cannabis Stock Gainers And Losers From August 14, 2023 ↗

August 14, 2023

Via Benzinga

Topics Cannabis

Why Are Cannabis Stocks Trading Higher Today? ↗

April 27, 2023

Cannabis stocks shot up in Thursday's pre-market and are holding.

Via Benzinga

Cannabis Stock Movers For August 10, 2023 ↗

August 10, 2023

Via Benzinga

Topics Cannabis

InterCure Teams Up With TYSON 2.0 In Israel, Australia, United Kingdom, Germany And Other EU Countries ↗

April 20, 2023

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) and TYSON 2.0 have entered into a binding letter of intent for a business partnership.

Via Benzinga

Nasdaq Down 80 Points; VirTra Shares Spike Higher ↗

April 03, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P...

Via Benzinga

Marijuana Stock Movers For August 9, 2023 ↗

August 09, 2023

Via Benzinga

Topics Cannabis

Marijuana Stock Movers For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Cannabis Stock Movers For July 24, 2023 ↗

July 24, 2023

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.